QDVSX | RNPGX | QDVSX / RNPGX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 5 years | 15 years | - |
Gain YTD | 18.725 | 14.733 | 127% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 250 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 296K | 145B | 0% |
Annual Yield % from dividends | 1.43 | 1.11 | 129% |
Returns for 1 year | 25.52 | 18.62 | 137% |
Returns for 3 years | 23.57 | -5.93 | -397% |
Returns for 5 years | N/A | 44.98 | - |
Returns for 10 years | N/A | 68.38 | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
ASMZX | 14.77 | -0.02 | -0.14% |
Alger Weatherbie Specialized Growth Z | |||
ABCIX | 23.60 | -0.04 | -0.17% |
American Beacon The London Co Inc Eq R5 | |||
JFNSX | 77.06 | -0.14 | -0.18% |
Janus Henderson Global Life Sciences S | |||
FIFPX | 21.62 | -0.07 | -0.32% |
Fidelity Founders M | |||
BKDEX | 10.24 | -0.05 | -0.49% |
BlackRock Defensive Advantage EM K |